Prev Arrow Stocks

IQVIA Holdings Inc. ($IQV) Stock Forecast: Down 5.2% Today

Morpher AI identified a bearish signal. The stock price may continue to fall based on the momentum of the negative news.

What is IQVIA Holdings Inc.?

IQVIA Holdings Inc. (IQV) operates in the clinical research and healthcare intelligence sector as a large-cap company. Over the last three months, the stock has surged by 23.1%, showcasing strong short-term performance that surpasses the S&P 500.

Why is IQVIA Holdings Inc. going down?

IQV stock is down 5.2% on Dec 4, 2025 14:42

  • Today, the market witnessed a bearish movement despite IQV's recent stock price increase and optimistic Q3 financial results.
  • The decline could be attributed to some investors seizing the opportunity to take profits after the stock's substantial growth in recent months.
  • Analysts' positive outlook on IQVIA Holdings, evident through the "Strong Buy" consensus rating and raised price targets, implies that the current bearish trend may be a temporary correction rather than a prolonged shift.
  • Amidst uncertainties in the broader market, investors appear to be reassessing their positions in IQVIA Holdings, resulting in a bearish movement despite favorable company-specific developments.

IQV Price Chart

IQV Technical Analysis

IQV News

IQVIA (IQV) Stock: Q3 2025 Results, 23% 3-Month Surge, and Analyst Outlook - News and Statistics

IQVIA Holdings Inc. (IQV) is trading 3% below its 52-week high after reporting strong Q3 2025 financial results, with revenue up 5.2% and adjusted EPS up 5.6% year-over-year. The stock has surged 23.1% in the past three months, outperforming the S&P 500, and analysts have a "Strong Buy" consensus rating with a 7.4% upside potential.

https://www.indexbox.io/blog/iqvia-holdings-stock-analysis-q3-2025-results-and-performance-review/

0 News Article Image  IQVIA (IQV) Stock: Q3 2025 Results, 23% 3-Month Surge, and Analyst Outlook - News and Statistics

Is IQVIA Holdings Stock Outperforming the S&P 500?

IQVIA Holdings Inc. (IQV) is a large-cap company providing clinical research and healthcare intelligence. The stock has outperformed the S&P 500 over the past three months and analysts rate it a "Strong Buy." Despite lagging the broader market over the past year, IQVIA reported strong Q3 results, beating revenue and EPS expectations.

https://www.barchart.com/story/news/36445183/is-iqvia-holdings-stock-outperforming-the-s-p-500

1 News Article Image Is IQVIA Holdings Stock Outperforming the S&P 500?

Is IQVIA Holdings Stock Outperforming the S&P 500?

IQVIA Holdings Inc. (IQV) has shown strong performance in the short term, with its stock soaring 23.1% over the past three months, outperforming the S&P 500's 6.2% gains. The company, valued at $38.4 billion, exceeded Q3 earnings expectations and boasts a "Strong Buy" consensus rating from analysts. While slightly lagging the broader market over longer periods, IQV demonstrates a bullish trend and significant upside potential.

https://markets.financialcontent.com/wral/article/barchart-2025-12-4-is-iqvia-holdings-stock-outperforming-the-s-and-p-500

2 Missing News Article Image Is IQVIA Holdings Stock Outperforming the S&P 500?

Is IQVIA Holdings Stock Outperforming the S&P 500?

IQVIA Holdings Inc. (IQV) has shown strong performance, with its stock soaring 23.1% over the past three months, outperforming the S&P 500. While it has slightly lagged the broader market over the longer term, its Q3 results exceeded expectations, leading to a "Strong Buy" consensus rating from analysts with a significant upside potential.

https://www.palmettograin.com/news/story/36445184/is-iqvia-holdings-stock-outperforming-the-s-p-500

3 Missing News Article Image Is IQVIA Holdings Stock Outperforming the S&P 500?

Morgan Stanley Raises Price Target on IQVIA Holdings to $265 From $250, Keeps Overweight Rating

Morgan Stanley has increased its price target for IQVIA Holdings (IQV) to $265 from $250, while maintaining an "Overweight" rating on the stock. This adjustment reflects continued positive sentiment from analysts towards the company, with other firms also recently raising their price targets. The article also provides key financial and operational details about IQVIA Holdings.

https://www.marketscreener.com/news/morgan-stanley-raises-price-target-on-iqvia-holdings-to-265-from-250-keeps-overweight-rating-ce7d51d9db8ff326

4 News Article Image Morgan Stanley Raises Price Target on IQVIA Holdings to $265 From $250, Keeps Overweight Rating

IQVIA Holdings Inc. Price History

28.09.2025 - IQV Stock was up 0.8%

  • IQVIA Holdings (IQV) reported better-than-expected earnings and revenue for the third quarter, indicating strong financial performance.
  • The company's focus on biopharma strength and cost control has likely contributed to the positive results, showcasing its ability to adapt to industry dynamics.
  • Investors may be optimistic about IQV's future prospects, considering its ability to outperform expectations in a challenging market environment.
  • The bullish movement in IQV's stock price could be a reflection of confidence in the company's strategic direction and growth potential.

24.06.2025 - IQV Stock was up 7.6%

  • IQV stock had a strong bullish movement today.
  • The positive earnings report for the second quarter, with earnings and revenue beating estimates and showing year-over-year growth, likely fueled the bullish trend.
  • Despite the strong performance, the cut in 2025 EBITDA guidance may have tempered some of the initial excitement in the market.
  • The overall market uncertainty could have been overshadowed by IQV's impressive financial results, leading to the bullish movement in the stock.

31.09.2024 - IQV Stock was down 5.0%

  • Despite surpassing earnings and revenue estimates in Q3 and demonstrating strength in key segments, IQV faced a bearish movement.
  • The market's reaction may stem from concerns regarding a potential deceleration in future growth or profit margins, notwithstanding the encouraging outcomes.
  • Investors could be capitalizing on gains after a period of robust performance, resulting in a brief decline in the stock price.
  • It is plausible that external factors, like broader market conditions or sector-specific developments, influenced the downward trend in IQV's stock price post the positive earnings disclosure.

07.04.2025 - IQV Stock was up 5.5%

  • Impressive Q1 earnings and revenues exceeded analysts' projections, particularly in the Research and Development, and Technology and Analytics sectors.
  • CEO's mention of the company's adept handling of uncertain market conditions boosted investor confidence and generated positive market sentiment towards IQVIA.
  • The increased sales outlook for 2025 and upheld EPS guidance added to the positive momentum, indicating a promising growth path for the company in the upcoming quarters.
  • IQVIA's strong financial performance and strategic positioning in significant segments drove the stock to a bullish trajectory, demonstrating investors' confidence in the company's future outlook.

06.01.2025 - IQV Stock was up 5.1%

  • The upcoming Q4 earnings report for IQVIA Holdings Inc. is anticipated to be positive, with expectations of a strong performance driven by the increasing adoption of GenAI technology to deliver valuable insights.
  • The market is responding favorably to the potential growth prospects associated with the rising use of advanced analytics in the healthcare sector, which is likely contributing to the bullish movement in IQV's stock price today.
  • Investors are showing confidence in IQV's ability to capitalize on the growing demand for data-driven solutions in the life sciences industry, positioning the company for continued success in the market.

08.06.2025 - IQV Stock was up 2.2%

  • A 29.88% increase in IQV's short percent of float could indicate a growing bearish sentiment among investors.
  • Despite the rise in short interest, the stock experienced a bullish movement, suggesting potential positive developments driving investor optimism.
  • Investor positivity may be linked to recent company announcements, strategic partnerships, or earnings reports, resulting in the upward movement of IQV's stock price.
  • Monitoring short interest data and market trends is crucial for traders to make informed decisions about IQV's future performance.

06.04.2025 - IQV Stock was down 4.4%

  • The bearish movement in IQV's stock today could be due to investors' concerns about the upcoming Q1 earnings.
  • Despite anticipated growth in the R&DS and TAS segments, investors may be cautious about the company's overall performance for the quarter.
  • Insights from analysts on key performance measures might have raised doubts or uncertainty among investors, leading to the bearish market movement.
  • Market participants may be waiting for the earnings release to gain a clearer picture of IQVIA's financial health and future outlook, causing the stock to decline in the short term.

10.03.2025 - IQV Stock was down 5.9%

  • Despite a recent surge in share price, IQVIA (IQV) experienced a strong bearish movement today.
  • The bullish movement in the last session may have been short-lived, as the latest trend in earnings estimate revisions does not support further price increase in the near term.
  • The market may have reacted negatively to this disconnect between the recent price surge and the lack of support from earnings estimates, leading to the bearish movement in IQV's stock today.

22.06.2025 - IQV Stock was up 15.7%

  • IQV is experiencing a strong bullish movement today, likely driven by positive market sentiment and anticipation surrounding its upcoming Q2 earnings.
  • Analysts are optimistic about IQV's performance for the quarter, with expectations of both earnings and revenues to rise on the back of strong demand across its segments.
  • Investors may be reacting positively to the potential growth in earnings, despite some concerns raised about the company not meeting all the key expectations for a likely earnings beat.
  • Overall, the bullish movement in IQV's stock today could be attributed to the market's optimism and anticipation of a positive earnings, outweighing any potential concerns about meeting all expectations.

11.02.2025 - IQV Stock was down 5.1%

  • Despite having a diversified client base and unique data offerings, IQVIA's stock experienced a bearish movement today.
  • The low liquidity concerns may have contributed to the downward trend in the stock price.
  • Investors might be cautious due to potential challenges related to liquidity, which could be impacting the market sentiment and driving the bearish movement in IQV's stock today.

22.06.2025 - IQV Stock was up 17.5%

  • IQVIA (IQV) experienced a strong bullish movement today following its Q2 earnings report.
  • The company surpassed earnings and revenue estimates for the quarter, showcasing a 6.4% increase in earnings and a 5.5% rise in revenue year-over-year.
  • Despite cutting its 2025 EBITDA guidance, investors were optimistic about IQVIA's performance, driven by strong demand across its segments.
  • The positive earnings report and optimistic outlook for the stock propelled IQV's bullish movement as investors showed confidence in the company's ability to deliver results in a competitive market.

04.11.2025 - IQV Stock was down 5.2%

  • Today, the market witnessed a bearish movement despite IQV's recent stock price increase and optimistic Q3 financial results.
  • The decline could be attributed to some investors seizing the opportunity to take profits after the stock's substantial growth in recent months.
  • Analysts' positive outlook on IQVIA Holdings, evident through the "Strong Buy" consensus rating and raised price targets, implies that the current bearish trend may be a temporary correction rather than a prolonged shift.
  • Amidst uncertainties in the broader market, investors appear to be reassessing their positions in IQVIA Holdings, resulting in a bearish movement despite favorable company-specific developments.
i
Disclaimer
Morpher is not liable for the content of the AI investment insights. Like most GPT-powered tools, these summaries may contain AI hallucinations and inaccurate information. Morpher is not presenting you with any investment advice. All investments involve risk, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Investors are fully responsible for any investment decisions they make. Such decisions should be based solely on an evaluation of their financial circumstances, investment objectives, risk tolerance, and liquidity needs. These summaries do not constitute investment advice.